Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lung Association of Nova Scotia, now operating as LungNSPEI, is a prominent non-profit health organization focused on improving respiratory health through advocacy, education, and community programs. The organization addresses critical issues such as asthma, COPD, lung cancer, and environmental health risks like radon exposure. Key initiatives include the Sleep Apnea Refurbishment Program, which provides equipment to those in need, and various support groups for patients and caregivers. By funding local research and promoting public health policies, the association works to reduce the prevalence of lung disease and improve the quality of life for residents in Nova Scotia and Prince Edward Island. The organization also provides resources for smoking cessation and air quality awareness to prevent the onset of respiratory conditions. Through community engagement and fundraising, they remain a vital pillar of the healthcare landscape in Atlantic Canada.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lung Association of Nova Scotia.